RECEPTOR CLASSIFICATION USING ANTAGONISTS WITHOUT DETERMINING PA2 VALUES

被引:4
作者
KROMER, W [1 ]
机构
[1] MED SCH HANNOVER,PHARMACOL,HANNOVER,GERMANY
关键词
D O I
10.1016/0165-6147(91)90482-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Albeit time-consuming, the most rigorous method of classification of receptor subtypes is the determination of pA2 values. However, this methodology requires the knowledge of absolute concentrations of both agonists and antagonists - something that may not necessarily be calculable under certain experimental conditions. Wolfgang Kromer offers a different method for classification using antagonists which is not dependent on absolute affinities, and which has the additional advantage of speed.
引用
收藏
页码:11 / 13
页数:3
相关论文
共 11 条
[1]   WILL THE TRUE RECEPTOR AFFINITY PLEASE STEP FORWARD [J].
BEVAN, JA ;
SHREEVE, SM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (02) :63-63
[2]   PHARMACOLOGICAL ANALYSIS OF MUSCARINIC RECEPTORS COUPLED TO OXYNTIC CELL SECRETION IN THE MOUSE STOMACH [J].
BLACK, JW ;
SHANKLEY, NP .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (03) :601-607
[3]   PHARMACOLOGICAL ANALYSIS OF THE INHIBITION BY PIRENZEPINE AND ATROPINE OF VAGAL-STIMULATED ACID-SECRETION IN THE ISOLATED STOMACH OF THE MOUSE [J].
BLACK, JW ;
SHANKLEY, NP .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (01) :291-297
[4]   AFFINITY AND SELECTIVITY OF BIPERIDEN ENANTIOMERS FOR MUSCARINIC RECEPTOR SUBTYPES [J].
ELTZE, M ;
FIGALA, V .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 158 (1-2) :11-19
[5]  
GIACHETTI A, 1986, TRENDS PHARM SCI S, V5, P88
[6]  
KENAKIN TP, 1984, PHARMACOL REV, V36, P165
[7]  
KROMER W, 1990, N-S ARCH PHARMACOL, V341, P165
[8]  
KROMER W, IN PRESS NAUNYNSCHMI
[9]   CAN EQUAL PA2 VALUES BE COMPATIBLE WITH RECEPTOR DIFFERENCES [J].
RAFFA, RB ;
VAUGHT, JL ;
PORRECA, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (05) :183-185
[10]   CORRELATION BETWEEN LOG POCT/H2O AND PKB ESTIMATES FOR A SERIES OF MUSCARINIC AND HISTAMINE H2-RECEPTOR ANTAGONISTS [J].
SHANKLEY, NP ;
BLACK, JW ;
GANELLIN, CR ;
MITCHELL, RC .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (01) :264-274